Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. GOOGL
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
(NASDAQ: KURA) Delayed: 10.36 +0.43 (4.33%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.54    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 1,383,616